Commerce: Clinical Trials

5 trials of Commerce, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Recruiting 1
Phase 11Completed 1

Follow Commerce: new trials by email Literature Review of Commerce trials Research Report on Commerce

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SNIFF Multi-Device Study 2
20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company), 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company) - Mild Cognitive Impairment, Cognitive Impairment
Phase 2CompletedWake Forest University Health Sciences132020-07-162026-10-07
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
gemcitabine and oxaliplatin., Afatinib - Gallbladder Carcinoma
Phase 2RecruitingShanghai Jiao Tong University School of Medicine1022020-06-012024-10-16
Building Sentences With Preschoolers Who Use AAC
AAC Generative Language Intervention, Standard of Care / Business as Usual - Down Syndrome, Speech and Language Disorder
Phase 2CompletedUniversity of Central Florida702018-05-112024-01-08
Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia
CBT, D-Cycloserine - Agoraphobia
Phase 2CompletedCharite University, Berlin, Germany732011-11-012014-05-19
Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
Pralatrexate Injection, Gemcitabine Hydrochloride, Vitamin B12 - Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma
Phase 1 / Phase 2CompletedAcrotech Biopharma Inc.1192007-05-012020-01-07

Conditions studied

Agoraphobia (1)  ·  Cognitive Dysfunction (1)  ·  Down Syndrome (1)  ·  Gallbladder Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Language Disorders (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoma, T-Cell, Peripheral (1)

Sponsors

Acrotech Biopharma Inc. (1)  ·  Charite University, Berlin, Germany (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  University of Central Florida (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (3)  ·  China (1)  ·  Germany (1)

Top investigators

Michael Saunders, MD (1)  ·  Suzanne Craft, PhD (1)  ·  Yingbin Liu, PHD (1)

Results publications

PMID 36854604

NIH funding

R01DC016321 (1)